Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125220501 | 12522050 | 1 | I | 20160616 | 20160701 | 20160701 | EXP | GB-APOTEX-2016AP009183 | APOTEX | 74.00 | YR | M | Y | 0.00000 | 20160701 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125220501 | 12522050 | 1 | PS | PERINDOPRIL 8 MG TABLETS | PERINDOPRIL | 1 | Oral | 4 MG, QD | U | U | 0 | 4 | MG | TABLET | |||||
| 125220501 | 12522050 | 2 | SS | IBUPROFEN. | IBUPROFEN | 1 | Oral | 400 MG, TID | U | U | 0 | 400 | MG | TID | |||||
| 125220501 | 12522050 | 3 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Unknown | 100 MG, QD | U | U | 0 | 100 | MG | ||||||
| 125220501 | 12522050 | 4 | C | BIMATOPROST. | BIMATOPROST | 1 | Ophthalmic | 1 DF, QD | U | U | 0 | 1 | DF | ||||||
| 125220501 | 12522050 | 5 | C | BRINZOLAMIDE | BRINZOLAMIDE | 1 | Ophthalmic | 1 DF, BID | U | U | 0 | 1 | DF | BID | |||||
| 125220501 | 12522050 | 6 | C | CETIRIZINE | CETIRIZINE HYDROCHLORIDE | 1 | Oral | 10 MG, QD | U | U | 0 | 10 | MG | ||||||
| 125220501 | 12522050 | 7 | C | DALTEPARIN SODIUM | DALTEPARIN SODIUM | 1 | Subcutaneous | 5000 IU, QD | U | U | 0 | 5000 | IU | ||||||
| 125220501 | 12522050 | 8 | C | DIHYDROCODEINE | DIHYDROCODEINE | 1 | Oral | 30 MG, QID | U | U | 0 | 30 | MG | QID | |||||
| 125220501 | 12522050 | 9 | C | DOUBLEBASE | ISOPROPYL MYRISTATEPARAFFIN | 1 | Topical | UNK, PRN | U | U | 0 | ||||||||
| 125220501 | 12522050 | 10 | C | FERROUS FUMARATE | FERROUS FUMARATE | 1 | Oral | 210 MG, TID | U | U | 0 | 210 | MG | TID | |||||
| 125220501 | 12522050 | 11 | C | FLUCLOXACILLIN | FLUCLOXACILLIN | 1 | Intravenous (not otherwise specified) | 2 G, QID | U | U | 0 | 2 | G | QID | |||||
| 125220501 | 12522050 | 12 | C | FLUTICASONE FUROATE | FLUTICASONE FUROATE | 1 | Nasal | 2 DF, QD | U | U | 0 | 2 | DF | ||||||
| 125220501 | 12522050 | 13 | C | FOSTAIR | BECLOMETHASONEFORMOTEROL | 1 | Respiratory (inhalation) | 2 DF, BID | U | U | 0 | 2 | DF | BID | |||||
| 125220501 | 12522050 | 14 | C | LACTULOSE. | LACTULOSE | 1 | Oral | 15 ML, BID | U | U | 0 | 15 | ML | BID | |||||
| 125220501 | 12522050 | 15 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Oral | 15 MG, QD | U | U | 0 | 15 | MG | ||||||
| 125220501 | 12522050 | 16 | C | LERCANIDIPINE | LERCANIDIPINE | 1 | Oral | 20 MG, QD | U | U | 0 | 20 | MG | ||||||
| 125220501 | 12522050 | 17 | C | MONTELUKAST | MONTELUKAST SODIUM | 1 | Oral | 10 MG, QD | U | U | 0 | 10 | MG | ||||||
| 125220501 | 12522050 | 18 | C | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | 1 G, QID | U | U | 0 | 1 | G | QID | |||||
| 125220501 | 12522050 | 19 | C | SALBUTAMOL | ALBUTEROL | 1 | Respiratory (inhalation) | 2 DF, PRN | U | U | 0 | 2 | DF | ||||||
| 125220501 | 12522050 | 20 | C | SENNA /00142201/ | SENNA LEAF | 1 | Oral | 15 MG, QD | U | U | 0 | 15 | MG | ||||||
| 125220501 | 12522050 | 21 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 20 MG, QD | U | U | 0 | 20 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125220501 | 12522050 | 1 | Product used for unknown indication |
| 125220501 | 12522050 | 2 | Product used for unknown indication |
| 125220501 | 12522050 | 3 | Product used for unknown indication |
| 125220501 | 12522050 | 4 | Product used for unknown indication |
| 125220501 | 12522050 | 5 | Product used for unknown indication |
| 125220501 | 12522050 | 6 | Product used for unknown indication |
| 125220501 | 12522050 | 7 | Product used for unknown indication |
| 125220501 | 12522050 | 8 | Product used for unknown indication |
| 125220501 | 12522050 | 9 | Product used for unknown indication |
| 125220501 | 12522050 | 10 | Product used for unknown indication |
| 125220501 | 12522050 | 11 | Product used for unknown indication |
| 125220501 | 12522050 | 12 | Product used for unknown indication |
| 125220501 | 12522050 | 13 | Product used for unknown indication |
| 125220501 | 12522050 | 14 | Product used for unknown indication |
| 125220501 | 12522050 | 15 | Product used for unknown indication |
| 125220501 | 12522050 | 16 | Product used for unknown indication |
| 125220501 | 12522050 | 17 | Product used for unknown indication |
| 125220501 | 12522050 | 18 | Product used for unknown indication |
| 125220501 | 12522050 | 19 | Product used for unknown indication |
| 125220501 | 12522050 | 20 | Product used for unknown indication |
| 125220501 | 12522050 | 21 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125220501 | 12522050 | OT |
| 125220501 | 12522050 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125220501 | 12522050 | Acute kidney injury | |
| 125220501 | 12522050 | Hypokalaemia | |
| 125220501 | 12522050 | Hypotension |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125220501 | 12522050 | 8 | 20160405 | 0 | ||
| 125220501 | 12522050 | 11 | 20160405 | 0 | ||
| 125220501 | 12522050 | 15 | 20160406 | 0 |